NDC 0517-2901 – Gvoke VialDx

Glucagon 1 mg/.2mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC0517-2901

Product details

Brand name
Gvoke VialDx
Generic name
Glucagon injection
Labeler
American Regent, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA212097
Marketed since
August 19, 2025
Marketing end
September 30, 2027
Pharmacologic class
Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Gvoke VialDx →

Package NDC codes (2)

Package NDCDescriptionSince
0517-2901-011 VIAL in 1 CARTON (0517-2901-01) / .2 mL in 1 VIALAug 19, 2025
0517-2901-1010 VIAL in 1 CARTON (0517-2901-10) / .2 mL in 1 VIALAug 19, 2025